Matthew R. Ruth, Chief Commercial Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 1,084 shares at $10.62 ($12K) on 2022-07-20, disclosed to the SEC on 2022-07-21.
Open-market sale of $12k OPNT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.